Impact of War on the Drug Supply for Cancer Patients in Sudan
DOI:
https://doi.org/10.54536/jir.v2i1.2408Keywords:
Chemotherapy, Drug supply, Cancer, Sudan, HealthcareAbstract
This review investigates the ramifications of conflict on chemotherapy drug accessibility for cancer patients in Sudan. For this review article, the data was collected from file records Port Sudan Oncology Center, Port Sudan, Sudan. Through a comprehensive analysis of drug supply frequencies during distinct conflict periods, the study reveals fluctuating availability and challenges in sustaining the supply chain. Grouping chemotherapy drugs according to their availability patterns elucidates the varying degrees of accessibility during conflict, ranging from consistent supplies to complete absence. The impact of these shortages on cancer patients is profound, resulting in compromised treatment outcomes, increased morbidity and mortality rates, and substantial socioeconomic burdens. Real-life patient accounts underscore the emotional, physical, and financial toll imposed by interrupted access to vital medications. Despite efforts by healthcare institutions, NGOs, and governmental bodies, persistent challenges hinder effective mitigation strategies during conflict, including logistical constraints, inadequate funding, and political instability. The socioeconomic and psychological implications of drug shortages are significant, pushing patients deeper into poverty and exacerbating psychological distress. Addressing these challenges necessitates sustained efforts to fortify drug supply chains, enhance infrastructure, and foster multi-stakeholder cooperation. The study emphasises the critical need for sustained interventions to ensure continuous access to chemotherapy drugs in Sudan and conflict zones globally. Immediate actions are imperative to alleviate the burdens faced by cancer patients and fortify healthcare systems to withstand the challenges of conflict-induced drug scarcity.
References
Al-Ibraheem, A., Abdlkadir, A. S., Mohamedkhair, A., Mikhail-Lette, M., Al-Qudah, M., Paez, D., & Mansour, A. H. (2022). Cancer diagnosis in areas of conflict. Frontiers in Oncology, 12, 1087476.
Aldaak, M., Suliman, H. M., Abd-Elgadir, E. E., & Abdoon, I. H. (2022). Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital. BMC Women’s Health, 22(1), 1-11.
Alpert, A., & Jacobson, M. (2019). Impact of oncology drug shortages on chemotherapy treatment. Clinical Pharmacology & Therapeutics, 106(2), 415-421.
Alrawa, S. S., Alfadul, E. S., Elhassan, M. M. A., & Hammad, N. (2023). Five months into conflict: near total collapse of cancer services in Sudan.
Babokhov, P., Sanyaolu, A. O., Oyibo, W. A., Fagbenro-Beyioku, A. F., & Iriemenam, N. C. (2013). A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis. Pathogens and global health, 107(5), 242-252.
Becker, D. J., Talwar, S., Levy, B. P., Thorn, M., Roitman, J., Blum, R. H., Harrison, L. B., & Grossbard, M. L. (2013). Impact of oncology drug shortages on patient therapy: unplanned treatment changes. Journal of oncology practice, 9(4), e122-e128.
Cardoso, F., Durbecq, V., Laes, J.-F., Badran, B., Lagneaux, L., Bex, F., Desmedt, C., Willard-Gallo, K., Ross, J. S., & Burny, A. (2006). Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2–positive breast cancer cells in a synergistic manner. Molecular cancer therapeutics, 5(12), 3042-3051.
Chan, M. (2018). Ten Years in Public Health 2007-2017: Report by Dr Margaret Chan Director-General World Health Organization. World Health Organization.
Dafallah, A., Elmahi, O. K., Ibrahim, M. E., Elsheikh, R. E., & Blanchet, K. (2023). Destruction, disruption and disaster: Sudan’s health system amidst armed conflict. Conflict and health, 17(1), 43.
Hashim, A. (2023). Attacks on healthcare facilities in Sudan: an unprecedented surge amid a military coup. Medicine, Conflict and Survival, 39(1), 86-92.
Huda, N., Shaw, M. K., & Chang, H.-J. (2022). Psychological distress among patients with advanced cancer: a conceptual analysis. Cancer nursing, 45(2), E487-E503.
Krikorian, G., & Torreele, E. (2021). We cannot win the access to medicines struggle using the same thinking that causes the chronic access crisis. Health and Human Rights, 23(1), 119.
Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder-DeWan, S., Adeyi, O., Barker, P., Daelmans, B., & Doubova, S. V. (2018). High-quality health systems in the Sustainable Development Goals era: time for a revolution. The Lancet global health, 6(11), e1196-e1252.
Lucero-Prisno III, D. E., Elhadi, Y. A. M., Modber, M. A. A., Musa, M. B., Mohammed, S. E. E., Hassan, K. F., Dafallah, A., Lin, X., Ahmadi, A., & Adeyemi, S. (2020). Drug shortage crisis in Sudan in times of COVID-19. Public Health in Practice, 1, 100060.
Mackintosh, M., Chaudhuri, S., & Mujinja, P. G. (2011). Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines. Globalization and health, 7, 1-13.
Muchiri, G., Okwii, M., Bukuluki, P., Willems, J., Amanyi-Enegela, J. A., Yibi, M., & Sankar, G. (2023). Challenges and strategies for the uptake of mass drug administration among pastoralist communities in South Sudan. Frontiers in Tropical Diseases, 4, 1007480.
Omotoso, O., Teibo, J. O., Atiba, F. A., Oladimeji, T., Paimo, O. K., Ataya, F. S., Batiha, G. E.-S., & Alexiou, A. (2023). Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions. International Journal for Equity in Health, 22(1), 189.
Organization, W. H. (2022). Country Cooperation Strategy for WHO and Sudan 2022–2025.
Palmater, P. (2015). Indigenous nationhood: Empowering grassroots citizens. Fernwood Publishing.
Phuong, J. M., Penm, J., Chaar, B., Oldfield, L. D., & Moles, R. (2019). The impacts of medication shortages on patient outcomes: a scoping review. PloS one, 14(5), e0215837.
Rajabi, M., Ebrahimi, P., & Aryankhesal, A. (2021). Collaboration between the government and nongovernmental organizations in providing health-care services: A systematic review of challenges. Journal of Education and Health Promotion, 10.
Sargidy, A. A. W., Yahia, A., Ahmad, M., Abdalla, A., Khalil, S. N., Alasiry, S., Shaphe, M. A., Mir, S. A., & Kashoo, F. Z. (2022). Knowledge of safe handling, administration, and waste management of chemotherapeutic drugs among oncology nurses working at Khartoum Oncology Hospital, Sudan. PeerJ, 10, e14173.
Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., Hu, S., Babar, Z.-U.-D., Fang, Y., & Yang, C. (2021). Drug shortage: causes, impact, and mitigation strategies. Frontiers in pharmacology, 12, 693426.
Stocker, K. J., Tiemann, A., Brunk, K. M., Agegnehu, B., Buhlinger, K., Amerine, L., Roberts, M. C., McLaughlin, J. E., Clark, S. M., & Rose, R. (2023). Processes and perceptions of chemotherapy supply chain in Ethiopia: A mixed-method study. Journal of Oncology Pharmacy Practice, 29(7), 1555-1564.
UniUnitm, P. (1982). Near East/North Africa Report.
Weber, G. F. (2015). Molecular therapies of cancer. Springer.
Yazdanian, A. (2020). Oncology information system: A qualitative study to identify cancer patient care workflows. Journal of Medicine and Life, 13(4), 469.
Yun, J.-A., Kim, H. C., Son, H.-S., Kim, H. R., Yun, H. R., Cho, Y. B., Yun, S. H., Lee, W. Y., & Chun, H.-K. (2010). Oncologic outcome after cessation or dose reduction of capecitabine in patients with colon cancer. Journal of the Korean Society of Coloproctology, 26(4), 287.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mona Mahmoud Abasher, Hyffa Osman Mohamed Ahmed, Eman Eltag Abdelateef
This work is licensed under a Creative Commons Attribution 4.0 International License.
